Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Artiva Biotherapeutics Inc (ARTV)

Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 249,205
  • Shares Outstanding, K 24,289
  • Annual Sales, $ 33,492 K
  • Annual Income, $ -27,696 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta N/A
  • Price/Sales 95.80
  • Price/Cash Flow N/A
  • Price/Book 1.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.72
  • Number of Estimates 4
  • High Estimate -0.58
  • Low Estimate -0.80
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.68 +5.99%
on 12/20/24
13.14 -21.92%
on 12/11/24
-1.54 (-13.05%)
since 12/06/24
3-Month
9.68 +5.99%
on 12/20/24
16.87 -39.18%
on 10/11/24
-4.60 (-30.96%)
since 10/08/24

Most Recent Stories

More News
Stocks Set to Open Lower as Investors Trim Risk Amid Year-End Uncertainty

March S&P 500 E-Mini futures (ESH25) are down -0.22%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.20% this morning, adding to Friday’s declines on Wall Street, as market participants reduced...

NFLX : 875.00 (-0.48%)
JWN : 24.09 (-0.12%)
NVDA : 140.11 (-0.02%)
LW : 60.89 (-1.28%)
AAL : 17.60 (-0.51%)
ARTV : 10.26 (-3.02%)
ESH25 : 5,939.00 (-0.34%)
BYW6.D.DX : 10.800 (-2.26%)
VIRX : 0.1877 (-11.04%)
TSLA : 394.94 (+0.15%)
NQH25 : 21,266.25 (-0.44%)
RCKT : 11.79 (-6.06%)
AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy

Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its pipeline candidate, acimtamig (AFM13).The regulatory body granted the RMAT designation...

AFMD : 1.1900 (-9.85%)
CSTL : 32.72 (+1.71%)
SPRO : 1.0000 (-4.76%)
ARTV : 10.26 (-3.02%)
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

ARTV : 10.26 (-3.02%)
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

ARTV : 10.26 (-3.02%)
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

ARTV : 10.26 (-3.02%)
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment

Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.

ARTV : 10.26 (-3.02%)

Business Summary

Artiva Biotherapeutics Inc. is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. The company's lead program includes AlloNK(R). Artiva Biotherapeutics Inc. is based in SAN DIEGO....

See More

Key Turning Points

3rd Resistance Point 12.76
2nd Resistance Point 12.15
1st Resistance Point 11.21
Last Price 10.26
1st Support Level 9.66
2nd Support Level 9.05
3rd Support Level 8.11

See More

52-Week High 17.31
Fibonacci 61.8% 14.40
Fibonacci 50% 13.49
Fibonacci 38.2% 12.59
Last Price 10.26
52-Week Low 9.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar